Author: Ishiwari, Mayuko; Togashi, Yuki; Takoi, Hiroyuki; Kikuchi, Ryota; Kono, Yuta; Abe, Shinji
Title: Polymyxin B haemoperfusion treatment for respiratory failure and hyperferritinaemia due to COVIDâ€19 Cord-id: hkthe2e9 Document date: 2020_11_1
ID: hkthe2e9
Snippet: A 69â€yearâ€old man with a history of type 2 diabetes and high blood pressure was diagnosed with coronavirus disease 2019 (COVIDâ€19). He had hyperferritinaemia and respiratory failure. Despite the initiation of favipiravir and highâ€dose corticosteroid and ceftriaxone, his respiratory failure progressed and serum ferritin levels increased. After polymyxin Bâ€immobilized fibre column direct haemoperfusion (PMXâ€DHP) therapy, there was improvement of the respiratory failure and hyperferriti
Document: A 69â€yearâ€old man with a history of type 2 diabetes and high blood pressure was diagnosed with coronavirus disease 2019 (COVIDâ€19). He had hyperferritinaemia and respiratory failure. Despite the initiation of favipiravir and highâ€dose corticosteroid and ceftriaxone, his respiratory failure progressed and serum ferritin levels increased. After polymyxin Bâ€immobilized fibre column direct haemoperfusion (PMXâ€DHP) therapy, there was improvement of the respiratory failure and hyperferritinaemia. We report the first case of COVIDâ€19â€induced hyperferritinaemia and severe respiratory failure successfully treated by PMXâ€DHP.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date